
Novo Nordisk A/S
NONOF | OTC
$39.22
-$0.70 (-1.75%)
Sep 22, 2026, 10:38 AM ET · Market open
Fiscal Year Period Ending | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 | FY 2019 Dec 30, 2019 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 15.66B | 14.39B | 12.65B | 10.72B | 12.76B | 15.48B |
Short-Term Investments | 10.65B | 15.84B | 10.92B | 6.77B | n/a | n/a |
Long-Term Investments | 2.68B | 1.66B | 1.34B | 1.44B | 1.65B | 1.81B |
Other Long-Term Assets | 4.02B | 1.43B | 206M | 267M | 674M | 841M |
Receivables | 87.41B | 75.26B | 57.51B | 46.8B | 32.18B | 29.15B |
Inventory | 40.85B | 31.81B | 24.39B | 19.62B | 18.54B | 17.64B |
Other Current Assets | 6.33B | 2.34B | 2.73B | 7.85B | 6.78B | 4.43B |
Total Current Assets | 160.9B | 139.65B | 108.19B | 85.6B | 65.81B | 62.46B |
Property-Plant & Equipment | 162.49B | 90.96B | 66.67B | 55.36B | 50.27B | 50.55B |
Goodwill & Intangibles | 111.09B | 60.41B | 50.94B | 43.17B | 20.66B | 5.84B |
Total Long-Term Assets | 304.9B | 174.84B | 133.06B | 108.91B | 79.11B | 63.16B |
Total Assets | 465.8B | 314.49B | 241.26B | 194.51B | 144.92B | 125.61B |
Account Payables | 28.85B | 25.61B | 15.59B | 8.87B | 5.72B | 6.36B |
Deferred Revenue | n/a | n/a | n/a | 55.18B | 38.73B | 35.33B |
Short-Term Debt | 11.78B | 5.3B | 480M | 12.86B | 6.68B | 659M |
Other Current Liabilities | 165.85B | 38.14B | 103.89B | 21.78B | 18.37B | 15.82B |
Total Current Liabilities | 217.53B | 169.66B | 120.94B | 99.52B | 70.27B | 58.98B |
Long-Term Debt | 84.25B | 15.98B | 20.78B | 9.65B | n/a | n/a |
Other Long-Term Liabilities | 9.68B | 7.58B | 5.45B | 360M | 5.93B | 5.95B |
Total Long-Term Liabilities | 104.78B | 38.27B | 36.83B | 24.25B | 11.32B | 9.04B |
Total Liabilities | 322.31B | 207.93B | 157.77B | 123.76B | 81.6B | 68.02B |
Total Debt | 102.79B | 27.01B | 25.78B | 26.65B | 10.36B | 4.48B |
Book Value | 143.49B | 106.56B | 83.49B | 70.75B | 63.33B | 57.59B |
Book Value Per Share | 32.17 | 23.71 | 18.37 | 15.36 | 13.53 | 12.11 |
Common Stock | 446M | 451M | 456M | 462M | 470M | 480M |
Retained Earnings | 144.45B | 104.84B | 80.59B | 72B | 63.77B | 57.82B |
Comprehensive Income | -1.41B | 1.28B | 2.45B | -1.71B | -911M | -694M |
Shareholders Equity | 143.49B | 106.56B | 83.49B | 70.75B | 63.33B | 57.59B |
Total Investments | 13.33B | 17.5B | 12.26B | 8.21B | 1.65B | 1.81B |
Add to Watchlist
Select watchlists to add or remove NONOF